These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4146208)

  • 21. Evidence for an alpha- and beta2-receptor mediated inhibition of the twitch response in the guinea pig vas deferens by noradrenaline.
    von Euler US; Hedqvist P
    Acta Physiol Scand; 1975 Apr; 93(4):572-3. PubMed ID: 168733
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of amphetamine and cocaine on the response of the isolated guinea-pig vas deferens to noradrenaline, tyramine and nerve stimulation.
    De Moraes S; Do Carmo MM; Carvalho FV
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):199-208. PubMed ID: 4694354
    [No Abstract]   [Full Text] [Related]  

  • 23. Fade and desensitisation in guinea-pig ileum and vas deferens.
    Brown F; Graham JD; Taha SA
    Eur J Pharmacol; 1973 Apr; 22(1):64-74. PubMed ID: 4706883
    [No Abstract]   [Full Text] [Related]  

  • 24. Responsiveness of the rat vas deferens to catecholamines and electrical stimulation during an infection with Trypanosoma brucei.
    Adeboye OO; Oriowo MA
    Afr J Med Med Sci; 1984; 13(3-4):135-8. PubMed ID: 6099973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the adrenergic effects of orphenadrine in rat vas deferens.
    Pubill D; Canudas AM; Pallàs M; Sureda FX; Escubedo E; Camins A; Camarasa J
    J Pharm Pharmacol; 1999 Mar; 51(3):307-12. PubMed ID: 10344632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal influence on the neurogenic response of the hamster vas deferens.
    Belis JA; Longhurst PA
    J Urol; 1985 Apr; 133(4):729-32. PubMed ID: 2984440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The contractile response to and the release of noradrenaline by transmural nerve stimulation in the guinea-pig vas deferens and a comparison with the response to noradrenaline.
    Gillespie JS; Macrae IM
    Br J Pharmacol; 1983 Nov; 80(3):477-84. PubMed ID: 6416341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of depletion of the noradrenaline content on the response of the mouse vas deferens to electrical stimulation and to tyramine [proceedings].
    Marshall I; Nasmyth PA; Shepperson NB
    J Physiol; 1977 Feb; 265(1):45P-46P. PubMed ID: 850184
    [No Abstract]   [Full Text] [Related]  

  • 29. Mechanisms underlying postjunctional synergism between responses of the vas deferens to noradrenaline and ATP.
    Smith NC; Burnstock G
    Eur J Pharmacol; 2004 Sep; 498(1-3):241-8. PubMed ID: 15364001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased release of noradrenaline from stimulated guinea pig vas deferens after indomethacin treatment.
    Fredholm B; Hedqvist P
    Acta Physiol Scand; 1973 Apr; 87(4):570-2. PubMed ID: 4724995
    [No Abstract]   [Full Text] [Related]  

  • 31. Relationship between alpha-adrenoceptor occupancy and contractile response in rat vas deferens. Experimental and theoretical analysis.
    Díaz-Toledo A; Martí MC
    Eur J Pharmacol; 1988 Nov; 156(3):315-24. PubMed ID: 2850930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
    Mallard N; Marshall R; Sithers A; Spriggs B
    Eur J Pharmacol; 1992 Sep; 220(1):1-10. PubMed ID: 1330614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Denervation supersensitivity to norepinephrine in the guinea-pig vas deferens in vivo and in vitro: influence of the bathing solution.
    Sannomiya P; De Moraes S
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):53-66. PubMed ID: 7305552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vas deferens smooth muscle responses to the nitric oxide-independent soluble guanylate cyclase stimulator BAY 41-2272.
    da Silva FH; Claudino MA; Báu FR; Rojas-Moscoso JA; Mónica FZ; De Nucci G; Antunes E
    Eur J Pharmacol; 2012 Aug; 688(1-3):49-55. PubMed ID: 22634166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Adrenoreactivity of different portions of the vas deferens in the rat].
    Berdysheva LV; Nesterova LA
    Fiziol Zh SSSR Im I M Sechenova; 1985 Nov; 71(11):1339-43. PubMed ID: 3002867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prazosin selectively inhibits the responses to field stimulation in the rat vas deferens.
    Doggrell SA
    Eur J Pharmacol; 1981 May; 71(4):447-53. PubMed ID: 6265241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tamsulosin and alfuzosin activity in the rat vas deferens: relevance to ejaculation delays.
    Tambaro S; Ruiu S; Dessi C; Mongeau R; Marchese G; Pani L
    J Pharmacol Exp Ther; 2005 Feb; 312(2):710-7. PubMed ID: 15470085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Supersensitivity to noradrenaline in vas deferens from morphine-dependent mice is confirmed.
    Rae GA; De Moraes S
    Eur J Pharmacol; 1983 Jan; 86(3-4):347-52. PubMed ID: 6682043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prazosin has low potency at α1A-adrenoceptors and high potency at α1D -adrenoceptors in rat vas deferens.
    Docherty JR
    Auton Autacoid Pharmacol; 2013 Oct; 33(3-4):49-57. PubMed ID: 24074250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A preliminary investigation of the mechanisms underlying cannabinoid tolerance in the mouse vas deferens.
    Pertwee RG; Griffin G
    Eur J Pharmacol; 1995 Jan; 272(1):67-72. PubMed ID: 7713151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.